BAMCO Inc
ASND icon

BAMCO Inc’s Ascendis Pharma A/S ASND Stock Holding History

BAMCO Inc’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Hold
5,600
– – ﹤0.01% 289
2025
Q4 		$1.19M Hold
5,600
– – ﹤0.01% 295
2025
Q3 		$1.11M Buy
+5,600
New +$1.04M ﹤0.01% 300
2023
Q2 		– Sell
-35,306
Closed -$3.79M – 345
2023
Q1 		$3.79M Hold
35,306
– – 0.01% 275
2022
Q4 		$4.31M Buy
35,306
+27,806
+371% +$3.23M 0.01% 280
2022
Q3 		$774K Buy
+7,500
New +$711K ﹤0.01% 335
2022
Q1 		– Sell
-20,500
Closed -$2.76M – 392
2021
Q4 		$2.76M Buy
+20,500
New +$3.05M 0.01% 339

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return